Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects-Reference-Cited by-同舟云学术

Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects

Published:2016-11-06 Issue:2 Volume:33 Page:225-229
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Bays Harold¹,Pi-Sunyer Xavier²,Hemmingsson Joanna Uddén³,Claudius Birgitte⁴,Jensen Christine B.⁴,Van Gaal Luc⁵

Affiliation:

1. Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA;

2. New York Obesity Research Center, Columbia University, New York, NY, USA;

3. Capio St Goran’s Hospital/Karolinska Institutet, Stockholm, Sweden;

4. Novo Nordisk A/S, Søborg, Denmark;

5. Department of Endocrinology, Diabetology and Metabolism, Faculty of Medicine, Antwerp University Hospital, Edegem, Belgium

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2016.1251892

Reference18 articles.

1. American Society for Metabolic and Bariatric Surgery, Obesity Society, American Society of Bariatric Physicians, American Association of Clinical Endocrinologists. Joint press release: obesity is a disease: leading obesity groups agree. PRNewswire website. 2013. Available at: http://www.prnewswire.com/news-releases/obesity-is-a-disease-leading-obesity-groups-agree-212194851.html [Last accessed 15 December 2015]

2. Adiposopathy and epigenetics: an introduction to obesity as a transgenerational disease

3. Obesity and its comorbid conditions

4. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis

5. The effect of weight loss on health-related quality of life: systematic review and meta-analysis of randomized trials

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks;Obesity Pillars;2024-12

2. The association of weight loss from anti‐obesity medications or bariatric surgery and apnea‐hypopnea index in obstructive sleep apnea;Obesity Reviews;2024-02-11

3. Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease;Frontiers in Endocrinology;2023-07-25

4. GLP‐1 analogs and regional adiposity: A systematic review and meta‐analysis;Obesity Reviews;2023-05-16

5. Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023;Obesity Pillars;2023-03